Gemina Laboratories Ltd. (GLABF)
OTCMKTS
· Delayed Price · Currency is USD
0.5305
-0.1995 (-27.33%)
At close: Apr 22, 2025
Gemina Laboratories Market Cap
Gemina Laboratories has a market cap or net worth of $56.68 million as of April 25, 2025. Its market cap has increased by 149.62% in one year.
Market Cap
56.68M
Enterprise Value
57.70M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.53
Market Cap Chart
Since August 11, 2021, Gemina Laboratories's market cap has increased from 17.07M to 56.68M, an increase of 232.12%. That is a compound annual growth rate of 38.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2025 | 56.68M | 38.67% |
Dec 27, 2024 | 40.88M | 36.33% |
Dec 29, 2023 | 29.98M | 26.61% |
Dec 30, 2022 | 23.68M | 41.55% |
Dec 29, 2021 | 16.73M | -1.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SS Innovations International | 1.74B |
Endo Inc. | 1.62B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 704.15M |
Northwest Biotherapeutics | 608.87M |
Elite Pharmaceuticals | 436.82M |
Glass House Brands | 384.26M |
CytoDyn | 264.36M |